Newsroom

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Celsius Holdings, Inc. (NASDAQ: CELH) securities between February 21, 2025 and June 3, 2026, inclusive (the "Class Period"). Celsius develops, processes, manufactures, markets, sells, and distributes products including energy drinks. The complaint alleges that defendant misled investors regarding the safety...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Unicycive Therapeutics (“Unicycive” or the “Company”) (NASDAQ: UNCY) securities during the period of December 29, 2025 through June 29, 2026, inclusive (“the Class Period”). Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or...

マイアミ--(BUSINESS WIRE)--（ビジネスワイヤ） -- Picsartは、世界中の1億以上のクリエイターと企業がコンテンツの制作、マーケティング、収益化を行うAIを活用したメディア制作・配信プラットフォームで、ルシネ・イェギアザリャンを最高財務責任者（CFO）に任命したと発表しました。 イェギアザリャンは、Picsartが業界をリードするクリエイティブ・プラットフォームとしての従来の枠を超え、動画ファーストでAIを活用した制作エコシステムの構築へと事業を拡大する重要な局面で、同社に加わります。この取り組みはすでに進んでおり、AI機能の提供開始以来、PicsartユーザーがAIを使って作成した動画・画像は11億点を超え、年初来のAI利用は前年同期比270%増となっています。これは、急成長するAIコンテンツ市場でのシェア拡大に向けた同社の取り組みが加速していることを示しています。1 最高財務責任者（CFO）として、イェギアザリャンはグローバルな財務戦略を統括し、事業拡大と長期的な成長を推進します。就任後の最優先課題は、財務規律と、AIを軸とした事業拡大に必要なイノベーショ...

ميامي--(BUSINESS WIRE)--اليوم، أعلنت Picsart، منصة إنتاج الوسائط المدعومة بالذكاء الاصطناعي وتوزيعها، والتي تضم أكثر من 100 مليون من المبدعين والشركات حول العالم، عن تعيين السيدة Lusine Yeghiazaryan في منصب المدير المالي.يتناول هذا البيان الصحفي الوسائط المتعددة. يمكنك الاطلاع على البيان كاملاً هنا: https://www.businesswire.com/news/home/20260903910923/ar/Picsart, the AI media production and distribution platform, where 100M+ creators and businesses worldwide make, market and monetize content, t...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s ETCAMAH® (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, based on a US Food and Drug Administration (FDA)-authorized test...

CLEVELAND--(BUSINESS WIRE)--ErieView Development today announced the closing of financing for the $218 million conversion of Erieview Tower — turning the 40-story 1964 landmark at East Ninth Street and St. Clair Avenue into the 210-key W Cleveland hotel, expected to be the first W Hotel in Ohio, and 215 W Apartments offered for rent rather than for sale, a first for the brand worldwide. The hotel and residences are scheduled to open around late 2027. The amenity program is the most extensive as...

BALL GROUND, Ga.--(BUSINESS WIRE)--Ameribrands, a diversified platform of specialized businesses serving the restaurant, retail, hospitality, entertainment, education and facilities sectors, recently announced the acquisition of Randal Retail Group, a leading provider of retail design, fixture manufacturing, merchandising displays and installation services. The acquisition significantly strengthens Ameribrands’ retail capabilities and advances its strategy of building a premier national platfor...

ROSWELL, Ga.--(BUSINESS WIRE)--Eirion Risk Underwriters launches an Inland Marine program: broad appetite, up to $25M capacity, and direct underwriter access....

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx as a companion diagnostic (CDx) to identify patients with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer harboring tumors with ESR1 mutations before radiographic progression who may benefit from treatment with ETCAMAH™ (camizestrant), AstraZeneca’s next-gener...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Acadia Healthcare Company, Inc. (NasdaqGS: ACHC).On September 27, 2024, the Company disclosed the receipt of a voluntary request for information from the U. S. Attorney’s Office for the Southern District of New York as well as a grand jury subpoena from the United States District Court...